Abstract:Objectives: In a blinded, prospective, randomized, controlled clinical trial, we compared nitrogen balance (NB), nutritional indices, antioxidant catalysts, and outcome in critically ill children given an immune-enhancing formula (I) or conventional early enteral nutrition (C). Methods: Fifty patients, 103 +/- 7 months old, with disorders prompting admission to the pediatric intensive care unit, including sepsis, respiratory failure, and severe head injury, were enrolled in the study. Within 12 h of admission, patients were randomized to receive I (n=25) or C (n=25). Caloric intake was aimed at meeting patient's predicted basal metabolic rate by day 2 and predicted energy expenditure by day 4, irrespective of group assignment. Outcome endpoints and complications were recorded; NB, transthyretin, retinol-binding protein, transferrin, zinc, copper, and metabolic indices were measured on days 1 and 5 and compared with clinical and nutritional characteristics within and between groups. Results: Both diets achieved their initial targets of covering predicted basal metabolic rate by day 2 and predicted energy expenditure by day 4. Twenty four-hour NB became positive in 40% of patients in group C and occurred in 64% of patients in group I by day 5. Only in group I did the mean NB become positive by day 5 (0.07+/-0.07 g/kg versus -0.24+/-0.03 g/kg on day 1, P<0.001) compared with group C in which the mean NB remained negative (-0.06+/-0.04 g/kg versus -0.25+/-0.06 g/kg on day 1, P<0.001). By day 5, nutritional indices and antioxidant catalysts showed a higher increasing trend in group I compared with group C and higher osmolality (P<0.02), sodium (P<0.03), and urea (P<0.04). Diarrhea for group I (P<0.02) and gastric distention for group C (P<0.04) were the most frequently recorded complications. Mortality or length of stay did not differ between groups, but there was a trend for less gastric gram plus isolates (P<0.05) or for Candida species (P<0.04) and nosocomial infections in group I compared with group C. Conclusions: Although less well tolerated, immunonutrition is a feasible method of early enteral nutrition in the pediatric intensive care unit. It has a favorable effect on nutritional indices and antioxidant catalysts, but not on outcome hard endpoints. Although it poses a higher metabolic burden to the patient, it shows a trend to improve colonization and infection rates. Appropriate modifications for specific age populations might improve its tolerability and benefits among critically ill children.

The Influence of the Enhanced Enteral Nutrition on Nutritional Status and Immune Function in Children with HIV/AIDS

Effect of Glutamine Fortifying Enteral Nutrition on Nutritio and Immunity in Children with Acquired Immune Deficiency Syndrome

Effect of Enteral Nutrition on T Lymphocytes-Mediated Immune Function in Patients with Acquired Immune Deficiency Syndrome

Effect of Nutritional Support on Immunity Function in the Acquired Immune Deficiency Syndrome Patients

Whole-protein enteral nutrition formula supplementation reduces Escherichia and improves intestinal barrier function in HIV-infected immunological non-responders.

Nutritional Efficacy of Glutamine-Supplemented Parenteral Nutrition in Children Undergoing Hematopoietic Stem Cell Transplantation

Effects of Immune-Enhanced Enteral Nutrition and Parenteral Nutrition on Immune and Nutritional Function in Elderly Patients with Gastric Cancer after Total Gastrectomy

Nutritional effects of glutamine-enriched parenteral nutrition in critical patients

Effect of glutamine on immune modification in malnourished patients with chronic obstructive pulmonary disease

Effect of L-glutamine on Nutritional Support and Immune Function in Patients with Chronic Respiratory Failure

Pre-Digested Protein Enteral Nutritional Supplementation Enhances Recovery of CD4+ T Cells and Repair of Intestinal Barrier in HIV-Infected Immunological Non-Responders

Effect of alanyl-glutamine on nutrition and immune in patients with respiratory failure

Clinical Study of Glutamine Combined with Early Enteral Nutrition Support on Nutritional Status of Gastric Cancer Patients Undergoing Neoadjuvant Chemotherapy

Clinical Application of Immune-Enhanced Enteral Nutrition in Patients with Advanced Gastric Cancer after Total Gastrectomy

The presence of enteropathy in HIV infected children on antiretroviral therapy in Malawi

Clinical Study of Early Enteral Immunonutrition in Senile Patients with Postoperative Pancreatic Cancer and Gastric Cancer

Effect of Glutamine Cellular Immune Modification to Malnourished Patients with COPD

Nutritional disorders in HIV disease

Early enteral nutrition supplemented with glutamine on the clinical outcomes of patients after total gastrectomy

Influence of different enteral nutritional support regimens on the nutritional status of post-operative patients with gastric cancer

Early enteral administration of immunonutrition in critically ill children: results of a blinded randomized controlled clinical trial